Bioinformatics Market | Growth, Trends, and Forecast (2019-2024)

Market Snapshot

Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The propelling factors for the growth of the global bioinformatics market include the increasing demand for nucleic acid and protein sequencing, increasing initiatives from government and private organizations, accelerating growth of proteomics and genomics, and increasing research on molecular biology and drug discovery. Owing to the aforementioned factors, the global bioinformatics market is expected to experience a boost during the forecast period.

Bioinformatics is gaining importance, as large amounts of data generated through techniques, like nucleic acid and protein sequencing, require data management and interpretation for future researches and medical purposes. Hence, increasing demand is expected to drive the bioinformatics market during the forecast period.

The demand for differentially expressed genes, computational epigenetics, meta-analysis of microarray data, gene network, systems biology requirements, and gene-associating studies, among others, has had a major impact on the growth of the global bioinformatics market.

Thus, technical advancements, along with the advent of the NGS technology, have helped in the development of bioinformatics tools for analyzing a great amount of data. This has contributed to the growth of the global bioinformatics market.

There is also little research that has been done in the field of bioinformatics to expedite decision-making in healthcare. Within clinical or medical informatics, there is a rich history of research on systems designed to help care providers and patients (healthcare consumers) and make optimal decisions surrounding diagnosis and management.

Scope of the Report

As per the scope of the report, bioinformatics is the application of computational technology to gather, store, analyze, and integrate biological data. This data is used to procure information and is applied to gene-based drug discovery and development, protein structure studies, and the determination of the therapeutic efficacy of drugs.

By Product and Services

Knowledge Management Tools

Bioinformatics Platform
	Interventional/Surgical Simulators
	Sequence Analysis Platform
	Sequence Alignment Platform
	Sequence Manipulation Platform
	Structural and Functional Analysis Platform
	Other Bioinformatics Platforms

Bioinformatics Services
	Sequencing Services
	Database and Management Services
	Data Analysis
	Other Bioinformatics Services

By Application
		Microbial Genome
		Gene Engineering
		Drug Development
		Personalized Medicine
		Omics
		Other Applications

By End User
		Pharmaceutical
		Animal Study
		Agriculture
		Forensic science
		Other End Users

Geography

North America
	United States
	Canada
	Mexico

Europe
	Germany
	United Kingdom
	France
	Italy
	Spain
	Rest of Europe

Asia-Pacific
	China
	Japan
	India
	Australia
	South Korea
	Rest of Asia-Pacific

Middle East & Africa
	GCC
	South Africa
	Rest of Middle East & Africa

South America
	Brazil
	Argentina
	Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Personalized Medicine is the Segment under Application that is Expected to Grow the Fastest During the Forecast Period

Bioinformatics is an essential component in basic research and in the development of new concepts for diagnosis and therapy, as well as in clinical practice, in which these concepts are applied to treat patients. Some of the major drivers that help in the increasing demand for bioinformatics are, growing applications of bioinformatics in drug discovery and development and growing bioinformatics support in the development of personalized medicines and clinical diagnostics.

To understand key trends, Download Sample Report

Asia-Pacific Holds the Fastest Growth and is Expected to Follow the Same Trend over the Forecast Period

A large number of healthcare investments in the Asia-Pacific region are expected to drive the bioinformatics market. Furthermore, the high adoption of IoT technologies in this sector is expected to impact market growth in the region positively. Key countries, including China and India, are expected to propel the bioinformatics market in this region mainly.

To understand geography trends, Download Sample Report

Competitive Landscape

Many pharmaceutical companies are minimizing drug discovery budgets, as they are shifting their focus from outsourcing of the software to developing in-house tools, thus allowing them to customize their required applications to meet their needs and increasing workflow efficiency. The major global players in the bioinformatics market include Illumina, Thermo Fisher Scientific, and Agilent Technologies, among others.

Major Players

* Complete list of players covered available in the table of contents below

Download the market shares of key players in this industry.

1. INTRODUCTION
1. 1.1 Study Deliverables
2. 1.2 Study Assumptions
3. 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
1. 4.1 Market Overview
2. 4.2 Market Drivers
  1. 4.2.1 Increasing Demand for Nucleic Acid and Protein Sequencing
  2. 4.2.2 Increasing Initiatives from Governments and Private Organizations
  3. 4.2.3 Accelerating Growth of Proteomics and Genomics
  4. 4.2.4 Increasing Research on Molecular Biology and Drug Discovery
3. 4.3 Market Restraints
  1. 4.3.1 Lack of Well-defined Standards and Common Data Formats for Integration of Data
  2. 4.3.2 Data Complexity Concerns and Lack of User-friendly Tools
4. 4.4 Porter's Five Forces Analysis
  1. 4.4.1 Threat of New Entrants
  2. 4.4.2 Bargaining Power of Buyers/Consumers
  3. 4.4.3 Bargaining Power of Suppliers
  4. 4.4.4 Threat of Substitute Products
  5. 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
1. 5.1 By Product and Services
  1. 5.1.1 Knowledge Management Tools
  2. 5.1.2 Bioinformatics Platform
    1. 5.1.2.1 Interventional/Surgical Simulators
    2. 5.1.2.2 Sequence Analysis Platform
    3. 5.1.2.3 Sequence Alignment Platform
    4. 5.1.2.4 Sequence Manipulation Platform
    5. 5.1.2.5 Structural and Functional Analysis Platform
    6. 5.1.2.6 Other Bioinformatics Platforms
  3. 5.1.3 Bioinformatics Services
    1. 5.1.3.1 Sequencing Services
    2. 5.1.3.2 Database and Management Services
    3. 5.1.3.3 Data Analysis
    4. 5.1.3.4 Other Bioinformatics Services
2. 5.2 By Application
  1. 5.2.1 Microbial Genome
  2. 5.2.2 Gene Engineering
  3. 5.2.3 Drug Development
  4. 5.2.4 Personalized Medicine
  5. 5.2.5 Omics
  6. 5.2.6 Other Applications
3. 5.3 By End User
  1. 5.3.1 Pharmaceutical
  2. 5.3.2 Animal Study
  3. 5.3.3 Agriculture
  4. 5.3.4 Forensic science
  5. 5.3.5 Other End Users
4. 5.4 Geography
  1. 5.4.1 North America
    1. 5.4.1.1 United States
    2. 5.4.1.2 Canada
    3. 5.4.1.3 Mexico
  2. 5.4.2 Europe
    1. 5.4.2.1 Germany
    2. 5.4.2.2 United Kingdom
    3. 5.4.2.3 France
    4. 5.4.2.4 Italy
    5. 5.4.2.5 Spain
    6. 5.4.2.6 Rest of Europe
  3. 5.4.3 Asia-Pacific
    1. 5.4.3.1 China
    2. 5.4.3.2 Japan
    3. 5.4.3.3 India
    4. 5.4.3.4 Australia
    5. 5.4.3.5 South Korea
    6. 5.4.3.6 Rest of Asia-Pacific
  4. 5.4.4 Middle East & Africa
    1. 5.4.4.1 GCC
    2. 5.4.4.2 South Africa
    3. 5.4.4.3 Rest of Middle East & Africa
  5. 5.4.5 South America
    1. 5.4.5.1 Brazil
    2. 5.4.5.2 Argentina
    3. 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
1. 6.1 Company Profiles
  1. 6.1.1 Illumina Inc.
  2. 6.1.2 Life Technologies (Thermo Fischer Scientific)
  3. 6.1.3 Qiagen NV
  4. 6.1.4 Agilent Technologies
  5. 6.1.5 PerkinElmer
  6. 6.1.6 ABM
  7. 6.1.7 Accelrys Inc.
  8. 6.1.8 Geneva Bioinformatics SA
  9. 6.1.9 Ontoforce
  10. 6.1.10 Data4Cure
  11. 6.1.11 Life Map Sciences (Biotime)
7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments